ATRI — Atrion Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMid CapNeutral
- $556.37m
- $556.38m
- $183.51m
- 87
- 45
- 34
- 57
Annual cashflow statement for Atrion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 34.3 | 36.8 | 32.1 | 33.1 | 35 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.09 | 1.26 | 0.771 | 1.49 | 1.94 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.6 | -8.22 | -7.6 | -4.95 | -18.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 43.2 | 42.5 | 39.2 | 38.8 | 28.8 |
| Capital Expenditures | -17.5 | -20.4 | -21.9 | -15.8 | -33.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 12.4 | -24.4 | -8.95 | 17.8 | 18.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -5.08 | -44.8 | -30.8 | 2 | -15.3 |
| Financing Cash Flow Items | -0.09 | -0.579 | -0.055 | -0.585 | -0.633 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -9.54 | -11.3 | -31 | -31 | -41 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 28.6 | -13.7 | -22.6 | 9.81 | -27.5 |